Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

September 14, 2017 - 6:47 p.m.
Gilead Prices $3 Billion of Senior Unsecured NotesPrinter Friendly Version 
September 05, 2017 - 4:02 p.m.
Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Monday, September 11Printer Friendly Version 

Upcoming Events

Wednesday, October 4, 2017 through Sunday, October 8, 2017
IDWeek 2017
LocationSan Diego, CA
Friday, October 20, 2017 through Tuesday, October 24, 2017
The Liver Meeting 2017
LocationWashington, DC

Most Viewed Links

Updated 09/21/17
1.SEC Filings
2.Annual Reports
3.Stock Information
4.Earnings
5.Gilead Sciences Business Update
* Data collected 09/13/17 - 09/20/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$82.62
 Stock is Down 0.02 (0.02%)
Data as of 09/21/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play